<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biomedical and Pharmacology Journal</journalTitle>
          <issn>0974-6242</issn>
            <publicationDate>2015-03-15</publicationDate>
    
        <volume>8</volume>
        <issue>March Spl Edition</issue>

 
    <startPage>91</startPage>
    <endPage>97</endPage>

	    <publisherRecordId>2346</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Vaginal Lactobacilli and Pap Operon Expression in Uropathogenic Escherichia Coli</title>

    <authors>
	 


      <author>
       <name>Reza Ranjbar</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Mehdi Moazzami Goudarzi</name>


		
	<affiliationId>2</affiliationId>

      </author>
    

	 


      <author>
       <name>Nematollah Jounaidi</name>

		
	<affiliationId>3</affiliationId>
      </author>
    

	


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Molecular biology research center, Baqiyatallah University of medical science, Tehran, Iran.  </affiliationName>
    

		
		<affiliationName affiliationId="2">Department of Microbiology, Boroujerd Branch, Islamic Azad University, Boroujerd, Iran.   </affiliationName>
    
		
		<affiliationName affiliationId="3">Health Research Center, Baqiyatallah University of medical science, Tehran, Iran</affiliationName>
    
		
		
		
	  </affiliationsList>






    <abstract language="eng">The present study aims to evaluate the effects of lactobacillus by-products on pyelonephritis-associated pili pap  expression in <em>Escherichia (E.) coli</em>. Vaginal <em>lactobacillus rhamnosus</em> and <em>lactobacillus crispatus</em> species were isolated and the effects of their culture supernatants (CS) on <em>pap</em> promoter activity in uropathogenic<em> E</em>. <em>coli</em> (UPEC) were studied. A new reporter construct of pET28a including Iranian firefly luciferase coding sequence was used to assess the pap propotor activity. The <em>lactobacillus rhamnosus</em>  forced the <em> </em><em>pap</em> promoter  to turn off when UPEC was exposed to 1%, 1.1%, and 1.3% of the culture supernatant. In addition, <em>lactobacillus</em><em> crispatus</em> could continuously switch off <em>pap</em> promoter phase variations when UPEC was exposed to a serial dilution of culture supernatant. The findings showed therapeutic and preventive potential of   <em>lactobacillus rhamnosus</em> and <em>lactobacillus crispatus</em> for bacterial vaginitis and urinary tract infection (UTI) through controlling the virulence factors expression via their ecological origins.</abstract>

    <fullTextUrl format="html">https://biomedpharmajournal.org/vol8marchspledition/vaginal-lactobacilli-and-pap-operon-expression-in-uropathogenic-escherichia-coli/</fullTextUrl>

<keywords language="eng">

      
        <keyword><em>Escherichia coli</keyword>
      

      
        <keyword></em> Vaginitis</keyword>
      

      
        <keyword> Urinary Tract Infection</keyword>
      

      
        <keyword> <em>lactobacillus rhamnosus</keyword>
      

      
        <keyword></em> <em>lactobacillus crispatus</em></keyword>
      
</keywords>
  </record>
</records>